Organization | Jasper Clinic, Inc.

Jasper Clinic, Inc. Report issue

For profit Phase 1 Phase 4

Founded: Kalamazoo MI United States (2003)

Status: Acquired by MPI Research (2014) → now Charles River (2018)

Organization Overview

First Clinical Trial

2005

NCT00251030

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Jasper Clinic, Michigan

Active Ingredients

Drugs in Phase 4 Trials (3)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

nelfinavir (viracept) (1 trial)

omeprazole (prilosec) (1 trial)

Drugs in Phase 1 Trials (11)

card-024 (1 trial)

cxa-10 (3 trials)

edetic acid (1 trial)

ezetimibe (zetia) (1 trial)

medium chain triglyceride (1 trial)

plazomicin (Zemdri) (1 trial)

pravastatin (pravachol) (1 trial)

simvastatin (zocor) (1 trial)

soybean oil (Intralipid) (1 trial)

sucrose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Kidney Injury (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 14